Defining the genomic architecture of Age-related Macular Degeneration (AMD) to improve diagnosis, treatment, and prevention.
The consortium currently includes 33 academic and independent research institutes.
The International AMD Genomics Consortium (IAMDGC) was formed in 2012 to aggregate genetic and genomic data from research groups across the world, with the goal of illuminating the genetic architecture of AMD. The IAMDGC built upon the success of the AMDgene consortium, which started in 2010 under the leadership of Drs. Margaret Pericak-Vance and Jonathan Haines with the support of Dr. Hemin Chin, then the Director, Ocular Genetics and Center Core Grant Programs, Division of Extramural Research, National Eye Institute. The IAMDGC has greatly expanded the number of participating groups, the amount of genetic data, and the analytical methods of analyzing these data. It published the largest AMD GWAS to date, and the data from that GWAS have been used in subsequent publications to identify new loci.
Our work centers on
Expanding IAMDGC resources and datasets with a focus on family data and diverse genetic ancestry
Expanding the range of clinical diagnostic measures
Using an analytical hub infrastructure to perform detailed analyses of our collective and individual members’ data